My 2020: AbelsonTaylor’s Jay Carter
In this week’s My 2020 video, AbelsonTaylor’s Jay Carter talks life and leadership amid the pandemic, and the agency world’s path forward.
-
-
J&J makes a $100 million diversity pledge. Does it go far enough?
The pledge arrived as the pandemic continued its surge, with minority communities particularly hard hit, and as cultural dialogue heated up within the industry. -
MM+M is celebrating the brightest young talent in medical marketing
Nominations for MM+M 40 Under 40 are open until December 30, 2020. -
2020 MM+M Holiday Contest: Home for the Holidays
Entries should explore how the holidays take on new meaning this year.
LATEST NEWS
A sponsored MM+M podcast with Spectrum Science’s Liz Bryan and Dayna Hochstein
Hear about Spectrum’s involvement with the MM+M Pitch Slam, how to pitch virtually and why Spectrum is growing by leaps and bounds this year.
Five things for pharma marketers to know: Tuesday, November 24, 2020
AstraZeneca vaccine results impress; U.S. to begin distributing Regeneron antibody therapy; Merck acquires OncoImmune, maker of a COVID treatment.
What the government’s COVID-19 vaccination campaign will look like
The federal government and the private sector will have their work cut out for them encouraging people to get the vaccine, and telling them how to do so.
Five things for pharma marketers to know: Monday, November 23, 2020
Regeneron’s experimental coronavirus treatment receives emergency use approval; Pfizer/BioNTech request emergency use approval for COVID-19 vaccine; Vaccine could be distributed as soon as 24-hours after receiving approval.
Five things for pharma marketers to know: Friday, November 20, 2020
HHS pilot program brings rapid, POC coronavirus tests to five states; CDC: Americans should not travel for Thanksgiving; J&J makes a $100 million diversity pledge.
The Escalator: Spark Therapeutics adds chief strategy officer
Plus people moves at EmpiRx Health, Open Health Group and CMI/Compas.
GCI Health names Kristin Cahill its next global CEO
Cahill assumes the role on January 1, as current chief exec Wendy Lund departs for a comms role at Merck spinoff Organon.
Five things for pharma marketers to know: Thursday, November 19, 2020
Pfizer/BioNTech vaccine proves safe and effective; COVID death and hospitalization numbers surge; Biden taps pharma lobbyist for administration.
“It’s always interesting when there’s a new administration and a new political configuration”
Washington healthcare policy insider Terry Haines offers his thoughts on COVID relief, the future of the Affordable Care Act and more.
The MM+M Podcast 11.18.2020: Otsuka and WOCIP’s Dr. Charlotte Jones-Burton
Dr. Charlotte Jones-Burton, VP of Otsuka and president and co-founder of WOCIP, weighs in on recent statements concerning Vice-President-elect Kamala Harris’ Black heritage, and offers her take on other news.
